This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Enriquez-Sarano, M. Articles by Frye, R. L. Search for Related Content PubMed PubMed Citation Articles by Enriquez-Sarano, M. Articles by Frye, R. L. Related Collections Valvular heart disease CV surgery: valvular disease Related Article

(Circulation. 2003;108:253.)
© 2003 American Heart Association, Inc.

Editorials

Mitral Regurgitation

What Causes the Leakage Is Fundamental to the Outcome of Valve Repair

Maurice Enriquez-Sarano, MD; Hartzell V. Schaff, MD; Robert L. Frye, MD

From the Division of Cardiovascular Diseases and Internal Medicine (M.E.-S., R.L.F.) and Division of Cardiovascular Surgery (H.V.S.), Mayo Clinic, Rochester, Minn.

Correspondence to Dr Maurice Enriquez-Sarano, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail sarano.maurice@mayo.edu

Key Words: Editorials • mitral valve • regurgitation • surgery

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Mitral regurgitation (MR) has become the predominant mitral valve disease as a result of the regression of rheumatic diseases and the aging of the population. The high prevalence in the elderly of degenerative and ischemic MR implies that MR is currently a public health problem. Recent data suggest that MR has severe outcome implications that are dependent on the degree of regurgitation, both for MR due to organic disease of the mitral valve and MR due to ischemic heart disease. This combination of high prevalence and relatively high risk requires careful examination of therapies applicable to MR. Unfortunately for patients with MR, therapeutic approaches for both medical and surgical treatment have not been evaluated by the state-of-the-art method—ie, by randomized clinical trials. Therefore, observational studies form the basis of our clinical decision-making process, and the quality of evidence is less than optimal. Our assessment of the improvement of outcome provided by various strategies (eg, medical treatment versus untreated observation, surgical treatment versus medical treatment of asymptomatic patients, valve repair versus valve replacement in patients who require surgery) is based on observational studies that have intrinsic limitations. The first implication of this situation is that we need (for a lack of a stronger word) appropriately designed randomized clinical trials comparing various strategies of treatment. The second implication is that it is not surprising that various observational studies, such as that presented by Thourani and colleagues in the present issue of Circulation,¹ may have findings different from each other in accordance . . . [Full Text of this Article]

Related Article:

Outcomes and Long-Term Survival for Patients Undergoing Mitral Valve Repair Versus Replacement: Effect of Age and Concomitant Coronary Artery Bypass Grafting

Vinod H. Thourani, William S. Weintraub, Robert A. Guyton, Ellis L. Jones, Willis H. Williams, Sharif Elkabbani, and Joseph M. Craver
Circulation 2003 108: 298-304. [Abstract] [Full Text]

This article has been cited by other articles:

				J. Magne, N. Girerd, M. Senechal, P. Mathieu, F. Dagenais, J. G. Dumesnil, E. Charbonneau, P. Voisine, and P. Pibarot Mitral Repair versus Replacement for Ischemic Mitral Regurgitation: Comparison of Short-Term and Long-Term Survival Circulation, September 15, 2009; 120(11_suppl_1): S104 - S111. [Abstract] [Full Text] [PDF]

				P. Klein, J. J. Bax, L. J. Shaw, H. H.H. Feringa, M. I.M. Versteegh, R. A.E. Dion, and R. J.M. Klautz Early and late outcome of left ventricular reconstruction surgery in ischemic heart disease Eur. J. Cardiothorac. Surg., December 1, 2008; 34(6): 1149 - 1157. [Abstract] [Full Text] [PDF]

				C.-H. Chen, H.-J. Wei, W.-W. Lin, I. Chiu, S.-M. Hwang, C.-C. Wang, W.-Y. Lee, Y. Chang, and H.-W. Sung Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair Cardiovasc Res, October 1, 2008; 80(1): 88 - 95. [Abstract] [Full Text] [PDF]

				R. B. Prucz, E. S. Weiss, N. D. Patel, L. U. Nwakanma, A. S. Shah, and J. V. Conte The Impact of Surgical Ventricular Restoration on Mitral Valve Regurgitation Ann. Thorac. Surg., September 1, 2008; 86(3): 726 - 734. [Abstract] [Full Text] [PDF]

				D. C Oxorn Intraoperative echocardiography Heart, September 1, 2008; 94(9): 1236 - 1243. [Full Text] [PDF]

				R. Atoui, D. Shum-Tim, and R. C.J. Chiu Myocardial Regenerative Therapy: Immunologic Basis for the Potential "Universal Donor Cells" Ann. Thorac. Surg., July 1, 2008; 86(1): 327 - 334. [Abstract] [Full Text] [PDF]

				C.-C. Wang, C.-H. Chen, W.-W. Lin, S.-M. Hwang, P. C.H. Hsieh, P.-H. Lai, Y.-C. Yeh, Y. Chang, and H.-W. Sung Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction Cardiovasc Res, February 1, 2008; 77(3): 515 - 524. [Abstract] [Full Text] [PDF]

				J. I. Fann, N. B. Ingels Jr., and D. C. Miller Pathophysiology of Mitral Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 973 - 1012. [Full Text]

				J. H. Shuhaiber and H. Shuhaiber Letter Regarding Article by Gammie et al, "Influence of Hospital Procedural Volume on Care Process and Mortality for Patients Undergoing Elective Surgery for Mitral Regurgitation" Circulation, August 14, 2007; 116(7): e146 - e146. [Full Text] [PDF]

				A. J. Choure, M. J. Garcia, B. Hesse, M. Sevensma, G. Maly, N. L. Greenberg, L. Borzi, S. Ellis, E. M. Tuzcu, and S. R. Kapadia In Vivo Analysis of the Anatomical Relationship of Coronary Sinus to Mitral Annulus and Left Circumflex Coronary Artery Using Cardiac Multidetector Computed Tomography: Implications for Percutaneous Coronary Sinus Mitral Annuloplasty J. Am. Coll. Cardiol., November 21, 2006; 48(10): 1938 - 1945. [Abstract] [Full Text] [PDF]

				D. Detaint, T. M. Sundt, V. T. Nkomo, C. G. Scott, A. J. Tajik, H. V. Schaff, and M. Enriquez-Sarano Surgical Correction of Mitral Regurgitation in the Elderly: Outcomes and Recent Improvements Circulation, July 25, 2006; 114(4): 265 - 272. [Abstract] [Full Text] [PDF]

				T.-T. Ton-Nu, R. A. Levine, M. D. Handschumacher, D. J. Dorer, C. Yosefy, D. Fan, L. Hua, L. Jiang, and J. Hung Geometric Determinants of Functional Tricuspid Regurgitation: Insights From 3-Dimensional Echocardiography Circulation, July 11, 2006; 114(2): 143 - 149. [Abstract] [Full Text] [PDF]

				E. Buffolo, J. N. R. Branco, R. Catani, and the RESTORE Group End-stage cardiomyopathy and secondary mitral insufficiency surgical alternative with prosthesis implant and left ventricular restoration Eur. J. Cardiothorac. Surg., April 1, 2006; 29(Suppl_1): S266 - S271. [Abstract] [Full Text] [PDF]

				J. J. Minguell and A. Erices Mesenchymal Stem Cells and the Treatment of Cardiac Disease Experimental Biology and Medicine, January 1, 2006; 231(1): 39 - 49. [Abstract] [Full Text] [PDF]

				K. Eguchi, E. Ohtaki, T. Matsumura, K. Tanaka, T. Tohbaru, N. Iguchi, K. Misu, R. Asano, M. Nagayama, T. Sumiyoshi, et al. Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation Eur. Heart J., September 2, 2005; 26(18): 1866 - 1872. [Abstract] [Full Text] [PDF]

				I. A. Memon, Y. Sawa, S. Miyagawa, S. Taketani, and H. Matsuda Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 646 - 653. [Abstract] [Full Text] [PDF]

				T. Omae, Y. Kakihana, A. Mastunaga, I. Tsuneyoshi, K. Kawasaki, Y. Kanmura, and R. Sakata Hemodynamic Changes During Off-Pump Coronary Artery Bypass Anastomosis in Patients with Coexisting Mitral Regurgitation: Improvement with Milrinone Anesth. Analg., July 1, 2005; 101(1): 2 - 8. [Abstract] [Full Text] [PDF]

				H. K. Haider and M. Ashraf Bone marrow stem cell transplantation for cardiac repair Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2557 - H2567. [Abstract] [Full Text] [PDF]

				C. L. Athanasuleas, G. D. Buckberg, A. W.H. Stanley, W. Siler, V. Dor, M. Di Donato, L. Menicanti, S. Almeida de Oliveira, F. Beyersdorf, I. L. Kron, et al. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1439 - 1445. [Abstract] [Full Text] [PDF]

				F. Rodriguez, F. Langer, K. B. Harrington, F. A. Tibayan, M. K. Zasio, A. Cheng, D. Liang, G. T. Daughters, J. W. Covell, J. C. Criscione, et al. Importance of Mitral Valve Second-Order Chordae for Left Ventricular Geometry, Wall Thickening Mechanics, and Global Systolic Function Circulation, September 14, 2004; 110(11_suppl_1): II-115 - II-122. [Abstract] [Full Text] [PDF]

				M.-S. Tsai, J.-L. Lee, Y.-J. Chang, and S.-M. Hwang Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol Hum. Reprod., June 1, 2004; 19(6): 1450 - 1456. [Abstract] [Full Text] [PDF]

				Mitral Regurgitation: To Repair or To Replace? Journal Watch Cardiology, September 26, 2003; 2003(926): 3 - 3. [Full Text]